Investors must take note of Agilon Health Inc’s (AGL) performance last week, which was -2.23%.

On Monday, Agilon Health Inc (NYSE: AGL) was -2.23% drop from the session before settling in for the closing price of $2.24. A 52-week range for AGL has been $1.50 – $13.76.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

A company in the Healthcare sector has jumped its sales by 53.71% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -17.47%. With a float of $303.34 million, this company’s outstanding shares have now reached $411.96 million.

In an organization with 1117 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -1.22%, operating margin of -6.17%, and the pretax margin is -5.56%.

Agilon Health Inc (AGL) Insider and Institutional Ownership

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Agilon Health Inc stocks. The insider ownership of Agilon Health Inc is 26.36%, while institutional ownership is 80.57%. The most recent insider transaction that took place on Dec 13 ’24, was worth 55,085. In this transaction Director of this company bought 25,000 shares at a rate of $2.20, taking the stock ownership to the 73,166 shares. Before that another transaction happened on Dec 11 ’24, when Company’s Director bought 25,062 for $2.01, making the entire transaction worth $50,269. This insider now owns 66,144 shares in total.

Agilon Health Inc (AGL) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -17.47% per share during the next fiscal year.

Agilon Health Inc (NYSE: AGL) Trading Performance Indicators

You can see what Agilon Health Inc (AGL) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.29. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.16.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.82, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.35 in one year’s time.

Technical Analysis of Agilon Health Inc (AGL)

Let’s dig in a bit further. During the last 5-days, its volume was 3.92 million. That was inferior than the volume of 4.86 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 70.53%. Additionally, its Average True Range was 0.21.

During the past 100 days, Agilon Health Inc’s (AGL) raw stochastic average was set at 11.27%, which indicates a significant decrease from 57.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 93.49% in the past 14 days, which was lower than the 113.90% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $2.44, while its 200-day Moving Average is $4.65. However, in the short run, Agilon Health Inc’s stock first resistance to watch stands at $2.29. Second resistance stands at $2.38. The third major resistance level sits at $2.44. If the price goes on to break the first support level at $2.14, it is likely to go to the next support level at $2.08. The third support level lies at $1.99 if the price breaches the second support level.

Agilon Health Inc (NYSE: AGL) Key Stats

There are 412,018K outstanding shares of the company, which has a market capitalization of 902.32 million. As of now, sales total 4,316 M while income totals -262,600 K. Its latest quarter income was 1,451 M while its last quarter net income were -117,620 K.